Teva Pharmaceuticals USA recalls Olmesartan Medoxomil and Hydrochlorothiazide Tablets, 40 mg/25 mg, packaged in a) 30-count bottle (NDC 0093-7617-56),
Teva Pharmaceuticals USA recalls 40mg/25mg Olmesartan Medoxomil and Hydrochlorothiazide tablets due to failed dissolution specifications. Affected lots expire February 2019.
Lower-risk recall
Failed dissolution specifications
Contact the company & request your remedy
What happened, in plain English
Teva Pharmaceuticals USA is recalling certain 40 mg/25 mg Olmesartan Medoxomil and Hydrochlorothiazide tablets that failed dissolution specifications. This means the medication may not work as intended for people taking it. Read more at govinfonow.com/recall/39309-teva-olmesartan-hydrochlorothiazide-tablets-recall-failed-dissolution-specifications.
Source Summary by GovInfoNow · govinfonow.com/recall/39309-teva-olmesartan-hydrochlorothiazide-tablets-recall-failed-dissolution-specifications · Updated October 5, 2026 · FDA enforcement record: FDA #D-0381-2019
Cite this page
“Teva Olmesartan/Hydrochlorothiazide Tablets Recall: Failed Dissolution Specifications.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39309-teva-olmesartan-hydrochlorothiazide-tablets-recall-failed-dissolution-specifications. Based on FDA recall #D-0381-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0381-2019%22&limit=1).
Why it’s dangerous
The tablets failed to dissolve properly as required by the manufacturer's specifications. This could mean the medication doesn't work correctly when taken.
Who’s affected
People with prescriptions for these specific tablets are affected. Those who have the recalled lots (expiring February 2019) are most at risk.
How to tell if you have this one
Check for the 30-count or 90-count bottles with NDC numbers 0093-7617-56 or 0093-7617-98. The lots expire February 2019 (49O005, 49O006, 49O007, 49O010).
- Brand
Teva Pharmaceuticals- Category
Drug
What to do — step by step
Check Product Details
Look for the NDC numbers 0093-7617-56 or 0093-7617-98 on the bottle.
Questions people ask
Why is this medication being recalled?
The tablets failed to dissolve properly as required by the manufacturer's specifications.
What should I do if I have these tablets?
The recall record does not specify a remedy for this product.
How can I tell if I have the recalled product?
Check for the 30-count or 90-count bottles with NDC numbers 0093-7617-56 or 0093-7617-98, and lots expiring February 2019.
Contact Teva Pharmaceuticals
We’ve drafted a message you can send Teva Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-0381-2019 — Teva Pharmaceuticals Teva Pharmaceuticals Hello, I own a Teva Pharmaceuticals that is covered by recall D-0381-2019 from Teva Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0381-2019 (December 19, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0381-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.